Open Access
EDITORIAL
Perspective. Digoxin for interstage single ventricle patients: What could possibly go wrong?
George F. Van Hare
* Corresponding Author: George F. Van Hare, Professor of Pediatrics (Cardiology), Department of Pediatrics, Washington University School of Medicine, One Children's Place/Campus Box 8116 – NWT, St. Louis, MO. Email:
Congenital Heart Disease 2019, 14(3), 321-323. https://doi.org/10.1111/chd.12760
Abstract
This article has no abstract.
Cite This Article
APA Style
Hare, G.F.V. (2019). Perspective. digoxin for interstage single ventricle patients: what could possibly go wrong?. Congenital Heart Disease, 14(3), 321-323. https://doi.org/10.1111/chd.12760
Vancouver Style
Hare GFV. Perspective. digoxin for interstage single ventricle patients: what could possibly go wrong?. Congeni Heart Dis. 2019;14(3):321-323 https://doi.org/10.1111/chd.12760
IEEE Style
G.F.V. Hare, "Perspective. Digoxin for interstage single ventricle patients: What could possibly go wrong?," Congeni. Heart Dis., vol. 14, no. 3, pp. 321-323. 2019. https://doi.org/10.1111/chd.12760